BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 24215280)

  • 1. Nanotechnologies for noninvasive measurement of drug release.
    Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F
    Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Therapeutic Nanomedicine.
    Joo J
    Adv Exp Med Biol; 2021; 1310():401-447. PubMed ID: 33834444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
    Khan AU; Khan M; Cho MH; Khan MM
    Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines.
    Dawidczyk CM; Kim C; Park JH; Russell LM; Lee KH; Pomper MG; Searson PC
    J Control Release; 2014 Aug; 187():133-44. PubMed ID: 24874289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.
    Sajja HK; East MP; Mao H; Wang YA; Nie S; Yang L
    Curr Drug Discov Technol; 2009 Mar; 6(1):43-51. PubMed ID: 19275541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the use of nanoparticles in cancer therapy and imaging.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional recruitment for drug delivery through protein-based nanotechnologies.
    Vazquez E; Mangues R; Villaverde A
    Nanomedicine (Lond); 2016 Jun; 11(11):1333-6. PubMed ID: 27221076
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
    Heneweer C; Gendy SE; Peñate-Medina O
    Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview.
    Lungu II; Grumezescu AM; Volceanov A; Andronescu E
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31574993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic and diagnostic applications of nanoparticles.
    Youns M; Hoheisel JD; Efferth T
    Curr Drug Targets; 2011 Mar; 12(3):357-65. PubMed ID: 20955146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of nanotechnology for the treatment of cancer: Recent advances.
    Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle delivery of cancer drugs.
    Wang AZ; Langer R; Farokhzad OC
    Annu Rev Med; 2012; 63():185-98. PubMed ID: 21888516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.